Chlorcyclizine 氯环嗪
CAS 82-93-9 MFCD00056036
化学结构图
SMILES: CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
化学属性
| Mol. Formula | C18H21ClN2 |
|---|---|
| Mol. Weight | 300.83 g/mol |
别名和识别编码
| Chemical Name | Chlorcyclizine |
|---|---|
| Wiswesser Line Notation | T6N DNTJ AYR&R DG& D1 |
| Synonym | 1-(4-Chlorobenzhydryl)-4-methylpiperazine 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine Chlorcycline Chlorcyclizine Histachlorazine chlorcycline chlorcyclizine chlorocyclizin {} {} {} {} {} {} {} {} {} {PubChem} chlorocyclizin {} {} {} {} {} {} {} {} {} {} {PubChem} chlorcyclizine {} {} {} {} {} {} {} {} {} {} {} {PubChem} chlorcycline {} {} {} {} {} {} {} {} {} {} {} {} {PubChem} Histachlorazine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {PubChem} chlorcyclizine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {PubChem} chlorcycline {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {PubChem} Histachlorazine {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} |
| CAS Number | 82-93-9 |
| Beilstein Registry Number | 0272719 |
| Chemical Name Translation | 氯环嗪 |
| PubChem Substance ID | 2710 |
| InChI | InChI=1S/C18H21ClN2/c1-20-11-13-21(14-12-20)18(15-5-3-2-4-6-15)16-7-9-17(19)10-8-16/h2-10,18H,11-14H2,1H3 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
安全信息
TYPE OF TEST : DNA inhibition ROUTE OF EXPOSURE : Intraperitoneal TEST SYSTEM : Rodent - rat DOSE/DURATION : 50 mg/kg REFERENCE : JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 171,109,1970
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE : 160 mg/kg SEX/DURATION : female 13-16 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - urogenital system REFERENCE : TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 17,76,1970
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE : 755 mg/kg SEX/DURATION : female 7-17 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - body wall Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 31,1225,1981
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Mammal - species unspecified DOSE : 440 mg/kg SEX/DURATION : female 15-25 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) REFERENCE : AOBIAR Archives of Oral Biology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1959- Volume(issue)/page/year: 13,1281,1968
{
京ICP备2020036287号